Study number 8530-629
Dates
Apr 10 2024-Apr 28 2024
Location
Dallas, Texas
Age
18-55
Gender
Both
Smoker
Compensation
$5,458
Group
A2
The purpose of this study is to measure how much of the study drug and its breakdown products get into the blood stream and how long it takes the body to get rid of them, when given with acetylsalicylic acid (Group 1) or mefenamic acid (Group 2). In addition, the safety and tolerability of the study drug will be evaluated when given alone, and in combination with acetylsalicylic acid (Group 1) or mefenamic acid (Group 2).
Fortrea Dallas, TX is recruiting for:
-Healthy Non-smoking Men and Women, age 18-55
-Body Mass Index between 18.5-30
-Study involves 1 stay of 11 nights & 1 follow-up visit
-Compensation up to $5,458 may be provided for time and participation
-Refer a friend to receive $350 per qualified referral
A2:
Check-in: Apr 10
Check-out: Apr 21
Outpatient visit: Apr 28